ABVC BIOPHARMA, INC. Logo

ABVC BIOPHARMA, INC.

Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.

ABVC | NDAQ

Overview

Corporate Details

ISIN(s):
US00091F1066
LEI:
Country:
United States of America
Address:
44370 OLD WARM SPRINGS BLVD., 94538 FREMONT
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing drugs and medical devices for unmet medical needs. The company specializes in botanical, plant-based therapies designed for high efficacy and low toxicity. Its development pipeline targets conditions in ophthalmology, oncology, and Central Nervous System (CNS) disorders, including major depressive disorder and adult ADHD. Key products in development include Vitargus®, a biodegradable vitreous replacement, and novel treatments for depression (ABV-1504) and ADHD (ABV-1505). The company in-licenses promising compounds from a global network of research institutions to advance them through clinical trials. Additionally, its subsidiary, BioKey, Inc., provides contract development and manufacturing services for nutritional and pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ABVC BIOPHARMA, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABVC BIOPHARMA, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ABVC BIOPHARMA, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France ALINT
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America INTS
InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America IDCC
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan 7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan 9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea 287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea 216400

Talk to a Data Expert

Have a question? We'll get back to you promptly.